doi: 10.1007/BF02953231.
Prostate-specific antigen. Superior serum marker for prostatic carcinoma
- PMID: 2440830
- DOI: 10.1007/BF02953231
Item in Clipboard
Prostate-specific antigen. Superior serum marker for prostatic carcinoma
Ir J Med Sci.
1987 May.
No abstract available
Similar articles
-
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.Tumour Biol. 1990;11(6):289-94. doi: 10.1159/000217664. Tumour Biol. 1990. PMID: 1700860
-
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.Clin Endocrinol (Oxf). 1997 Mar;46(3):333-42. Clin Endocrinol (Oxf). 1997. PMID: 9156044
-
[Effects of prostatic massage on serum levels of prostatic acid phosphatase and specific antigen].Bull Cancer. 1992;79(11):1097-100. Bull Cancer. 1992. PMID: 1284587 French.
-
The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate.Mo Med. 1991 Jun;88(6):349-52. Mo Med. 1991. PMID: 1712422 Review.
-
Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen.Urology. 2005 Dec;66(6):1320. doi: 10.1016/j.urology.2005.06.120. Urology. 2005. PMID: 16360475 Review.
Cited by
-
Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.J Natl Med Assoc. 1994 Sep;86(9):667-70. J Natl Med Assoc. 1994. PMID: 7525979 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical